SI1107744T1 - Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia - Google Patents

Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia

Info

Publication number
SI1107744T1
SI1107744T1 SI9930311T SI9930311T SI1107744T1 SI 1107744 T1 SI1107744 T1 SI 1107744T1 SI 9930311 T SI9930311 T SI 9930311T SI 9930311 T SI9930311 T SI 9930311T SI 1107744 T1 SI1107744 T1 SI 1107744T1
Authority
SI
Slovenia
Prior art keywords
fibromyalgia
antagonists
substance
treatment
chronic fatigue
Prior art date
Application number
SI9930311T
Other languages
Slovenian (sl)
Inventor
Wolfgang Mueller
Thomas Stratz
Lothar FÄRBER
Original Assignee
Novartis Ag
Wolfgang Mueller
Thomas Stratz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9818467.4A external-priority patent/GB9818467D0/en
Priority claimed from GBGB9826692.7A external-priority patent/GB9826692D0/en
Application filed by Novartis Ag, Wolfgang Mueller, Thomas Stratz filed Critical Novartis Ag
Priority claimed from PCT/EP1999/006215 external-priority patent/WO2000010545A2/en
Publication of SI1107744T1 publication Critical patent/SI1107744T1/en

Links

SI9930311T 1998-08-25 1999-08-24 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia SI1107744T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9818467.4A GB9818467D0 (en) 1998-08-25 1998-08-25 Organic compounds
GBGB9826692.7A GB9826692D0 (en) 1998-12-04 1998-12-04 Organic compounds
PCT/EP1999/006215 WO2000010545A2 (en) 1998-08-25 1999-08-24 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
EP99942911A EP1107744B1 (en) 1998-08-25 1999-08-24 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia

Publications (1)

Publication Number Publication Date
SI1107744T1 true SI1107744T1 (en) 2003-10-31

Family

ID=29254888

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930311T SI1107744T1 (en) 1998-08-25 1999-08-24 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia

Country Status (1)

Country Link
SI (1) SI1107744T1 (en)

Similar Documents

Publication Publication Date Title
BR9706968A (en) Use of alpha-ppar and gamma-ppar antagonists for the treatment of syndrome x
HUP0102033A3 (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
GB0109537D0 (en) Well treatment fluids and methods for the use thereof
ATE312608T1 (en) CABERGOLINE FOR THE TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
DE69502199T2 (en) FLOOR SURFACE FOR USE FOR SPORTS AND SIMILAR PURPOSES
GB2322065B (en) Apparatus for cleaning floors,carpets and the like
GB9816234D0 (en) Compounds for use in the treatment of inflammation
DE69327812D1 (en) ARSEN-CONTAINING MEDICINES FOR TREATING THE CHRONIC FATIGUE SYNDROME
ITCO980014A0 (en) DEVICE AND SYSTEM PROCEDURE FOR THE CLEANING TREATMENT OF IRREGULAR PIECES OF DIFFERENT MATERIALS
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
HK1033876A1 (en) Use of nmda antagonists for treatment of irritablebowel syndrome.
HUP0202339A3 (en) Use of cortisol antagonists in the treatment of heat failure
SI1107744T1 (en) Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia
DE59904938D1 (en) Suspension device for kitchen furniture and the like
ATE307600T1 (en) USE OF MYCOBACTERIUM VACCAE FOR THE THERAPY OF CHRONIC FATIGUE SYNDROME
AU5522301A (en) Treatment of fibromyalgia and chronic fatigue syndrome
HUP0102995A3 (en) Agents and method for the protective treatment of wood
SI1274430T1 (en) Cabergoline for the treatment of fibromyalgia and chronic fatigue syndrome
AU2002225881A1 (en) Treatment of chronic fatigue syndrome and fibromyalgia syndrome
AU5374898A (en) The use of oxandrolone in the treatment of chronic fatigue syndrome
PT1011678E (en) Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
AU3663601A (en) Human herpesvirus 6a and 6b transfer factors for the treatment of chronic fatigue syndrome and multiple sclerosis
IL127040A0 (en) Use of substituted azaspirane in the treatment of asthma
EP0979653A4 (en) Remedy for chronic fatigue syndrome